Trial
NCT01717846
Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, Los Angeles
Collaborators
Bristol-Myers Squibb
Condition
Apoptotic DNA Damage
Intervention
Group 1 or Orencia treated group
Why stopped
The PI has left UCLA and we do not plan to pursue this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-11